Definition of usual and customary price modified for purposes of medical assistance prescription drug reimbursement.
Impact
If enacted, HF4305 will significantly impact the operational protocols for pharmacies participating in the state’s medical assistance programs. By establishing clear guidelines for reimbursement related to the usual and customary prices, the bill seeks to ensure that pharmacies are reimbursed fairly while also maintaining the integrity of the state’s healthcare budget. Furthermore, it addresses a need for transparency in pricing, which is essential for both pharmacies and patients, especially in regard to drug availability and affordability.
Summary
House File 4305 proposes amendments to the existing laws concerning medical assistance and the reimbursement for prescription drugs in Minnesota. It aims to clarify the definition of 'usual and customary price' for the purposes of determining reimbursement rates for pharmacies. The bill suggests that reimbursement will be based on either the ingredient costs of drugs plus a professional dispensing fee or the lowest price charged to the public, expanding the scope of what may be considered in these calculations.
Contention
Nevertheless, the bill may face opposition from entities that perceive it as having the potential to limit pharmacy autonomy or influence the accessibility of medications for certain populations. Key points of contention may involve how the new definitions affect long-term care facilities and their prescription drug distribution. Advocacy groups might raise concerns regarding the implications on patient care if pharmacies limit interactions with certain programs or adapt their practices in response to the new reimbursement structure, therefore affecting patient access to necessary medications.
Coverage of medical services and prescription medications for the treatment of dementia required, and step therapy requirements for medical assistance modified.
Dispensing fee requirements imposed on health plan companies and county-based purchasing plans providing prescription drug coverage in the medical assistance program.
Dispensing fee requirements establishment on health plan companies and county-based purchasing plans providing prescription drug coverage in the medical assistance program
Dementia treatment medical services and prescription medications coverage requirement provision and step therapy requirements for medical assistance provision
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.